Concepedia

Richard A. Rifkind

RA

87

Publications

11.8K

Citations

53

H-Index

1957

Active since

Affiliations

Columbia University(Current)

Memorial Sloan Kettering Cancer Center

Cornell University

Richard A. Rifkind is an author at Columbia University specializing in medicine, cell biology, and developmental biology.

Top concepts

Publications per year

1957–2007

87

Publications

87

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

Michael S. Finnin, Jill R. Donigian, Alona Cohen et al. · Nature · 1999 · 1.7K citations

, , +11

Histone deacetylase inhibitor selectively induces p21 <sup>WAF1</sup> expression and gene-associated histone acetylation

Victoria M. Richon, Todd W. Sandhoff, Richard A. Rifkind et al. · Proceedings of the National Academy of Sciences · 2000 · 1.1K citations · Full text

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases

Victoria M. Richon, Stéphane Emiliani, Eric Verdin et al. · Proceedings of the National Academy of Sciences · 1998 · 911 citations · Full text

Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.

Wm. Kevin Kelly, Victoria M. Richon, Owen A. O’Connor et al. · PubMed · 2003 · 623 citations

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin

Lisa M. Butler, Xianbo Zhou, Weisheng Xu et al. · Proceedings of the National Academy of Sciences · 2002 · 506 citations · Full text

Rows per page

1–5 of 87